All News #Library
Biotech
Vanda Pharma Publishes Imsidolimab GPP Study in NEJM Evidence
29 Apr 2026 //
PR NEWSWIRE
Vanda Kicks Off NEREUS Trial for GLP-1-Induced Nausea
09 Apr 2026 //
PR NEWSWIRE
Vanda Tests Motion Sickness Drug Nereus In GLP-1 Patients
09 Apr 2026 //
FIERCE PHARMA
Vanda Slides After FDA Again Rejects Hetlioz For Jet Lag
08 Jan 2026 //
PR NEWSWIRE
Vanda Pharma Files BLA for Imsidolimab in GPP Psoriasis
15 Dec 2025 //
PR NEWSWIRE
Vanda Pharmaceuticals Q1 2025 Financial Results
07 May 2025 //
PR NEWSWIRE
Vanda & Anaptys Announce Agreement for Imsidolimab Development
03 Feb 2025 //
PR NEWSWIRE

Market Place
Sourcing Support